![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Infigratinib for CCA (OncLive) View |
![]() |
PROOF 301: Infigratinib Versus Gemcitabine Plus Cisplatin for CCA With FGFR2 Rearrangements (GI Oncology Now) View |
![]() |
PROOF: infigratinib as first-line therapy in patients with advanced CCA (VJOncology) View |
![]() |
PROOF 301: infigratinib vs. gem/cis in patients with CCA with an FGFR2 gene fusion/rearrangement (VJOncology) View |
![]() |
FGFR2 Inhibitors in Advanced Cholangiocarcinoma (Targeted Oncology) View |
![]() |
FGFR Inhibitors in Development for CCA (OncLive) View |
![]() |
FGFR3 Inhibitors for Upper Tract Urothelial Cancer (Grand Rounds in Urology) View |
![]() |
FGFR Inhibitor Clinical Trials (Targeted Oncology) View |
![]() |
FGFR Inhibitors for CCA u0026 Bladder Cancer (Targeted Oncology) View |
![]() |
ClarIDHy Phase III Trial of Ivosidenib in CCA (OncLive) View |